Less than 48 hours before the first major opioid trial began, Teva struck an $85 million deal with Oklahoma officials, about one-third what painkiller giant Purdue Pharma paid to settle similar claims. That leaves Johnson & Johnson as the only drugmaker facing trial Tuesday—and far more than 1,000 opioid lawsuits left to fight.
